Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Interv Neuroradiol ; 27(1): 99-106, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32693662

ABSTRACT

BACKGROUND AND PURPOSE: The Penumbra JET 7 reperfusion catheter is used in the revascularization of large vessel occlusions in acute ischemic stroke. Description of its use in clinical practice remains limited. Our purpose is to describe our initial experience with the Penumbra JET 7 reperfusion catheter and to report on its safety and efficacy in different thrombectomy techniques. MATERIALS AND METHODS: We conducted a retrospective study of 50 patients treated with thrombectomy using the Penumbra JET 7 reperfusion catheter. Mean patient age and admission National Institutes of Health Stroke Scale were 70.6 and 17.76, respectively. The most common sites of vessel occlusion were the M1 segment (72%) followed by distal internal carotid artery (14%). Thrombectomy was performed using the direct aspiration first-pass technique and/or aspiration in conjunction with a stent retriever. RESULTS: Revascularization was achieved in a total of 44 cases (88%). Successful navigation of the Penumbra JET 7 reperfusion catheter to the occlusion site with clot engagement was achieved in 94% of cases. Mean time from vascular access to revascularization was 31.60 min. No catheter-related complications occurred. Clinical outcome data were collected from 43 patients (86%). Of those patients, 51% achieved good outcome (modified Rankin score of 0-2) at 60 or more days follow-up, 28% had poor outcome (modified Rankin score of 3-5), and 9 patients died (21%). CONCLUSION: The use of the Penumbra JET 7 reperfusion catheter for treatment of acute ischemic stroke was observed to be safe and effective with appropriate revascularization outcomes in different thrombectomy techniques.


Subject(s)
Brain Ischemia , Ischemic Stroke , Stroke , Brain Ischemia/surgery , Catheters , Humans , Reperfusion , Retrospective Studies , Stents , Stroke/surgery , Thrombectomy , Treatment Outcome
2.
Drug Metab Lett ; 7(2): 137-40, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24856265

ABSTRACT

Pomelo fruit juice and pomelo ethylacetate extract have been shown to increase the bioavailability of some CYP3A substrates. The purpose of this study was to investigate if this effect might be contributed to by changes in CYP3A and p-glycoprotein mRNAs levels in the liver and proximal small intestine. The ethyl acetate extract of pomelo mix was administered for 7 days to 10 rabbits. Nine rabbits were administered tap water for 7 days. The administration was through oral intubation to the stomach. On the 8(th) day, the rabbits were sacrificed, and the liver and the proximal 15 cm of the small intestine were dissected. Total RNA was extracted from the specimens and cDNA was prepared by quantitative real-time-polymerase chain reaction (RT-PCR) using specific primers. The ethyl acetate extract of pomelo mix reduced the mRNA expression of CYP3A6 almost 5-folds in the intestine and 2-folds in the liver. In contrast, a 1-fold increase to the p-glycoprotein mRNA expression was observed under the same experimental conditions. In conclusion, the ethyl acetate extract of pomelo mix reduced the mRNA expression of CYP3A6 in both intestine and liver but to different degrees, while the p-glycoprotein mRNA expression was not reduced.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Acetates/chemistry , Aryl Hydrocarbon Hydroxylases/genetics , Citrus , Intestine, Small/drug effects , Liver/drug effects , Plant Extracts/pharmacology , Solvents/chemistry , Transcription, Genetic , Administration, Oral , Animals , Citrus/chemistry , Down-Regulation , Fruit , Intestine, Small/enzymology , Liver/enzymology , Plant Extracts/administration & dosage , Plant Extracts/isolation & purification , RNA, Messenger/metabolism , Rabbits , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...